Breast Pathology White Paper

Lunit said Tuesday that it has published research showing that its AI biomarker platform, Lunit SCOPE, can improve HER2 (human epidermal growth factor receptor 2) diagnosis in advanced bile duct cancer. The study was published in Laboratory...